{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:52:58Z","timestamp":1791291178692,"version":"4.3.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,8,27]],"date-time":"2012-08-27T00:00:00Z","timestamp":1346025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,8,27]],"date-time":"2012-08-27T00:00:00Z","timestamp":1346025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1038\/pr.2012.118","type":"journal-article","created":{"date-parts":[[2012,8,27]],"date-time":"2012-08-27T16:03:51Z","timestamp":1346083431000},"page":"495-501","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["High- and low-dose OPG\u2013Fc cause osteopetrosis-like changes in infant mice"],"prefix":"10.1038","volume":"72","author":[{"given":"Renee","family":"Bargman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Posham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Boskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"DiCarlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Verdelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen","family":"Raggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Pleshko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,27]]},"reference":[{"key":"BFpr2012118_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11154-008-9074-4","volume":"9","author":"MS Cheung","year":"2008","unstructured":"Cheung MS, Glorieux FH Osteogenesis Imperfecta: update on presentation and management. Rev Endocr Metab Dis 2008; 9:153\u201360.","journal-title":"Rev Endocr Metab Dis"},{"key":"BFpr2012118_CR2","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1210\/jc.2005-2413","volume":"91","author":"F Rauch","year":"2006","unstructured":"Rauch F, Munns C, Land C, Glorieux FH . Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuation. J Clin Endocrinol Metab 2006;91:1268\u201374.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFpr2012118_CR3","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1359\/JBMR.040814","volume":"19","author":"CF Munns","year":"2004","unstructured":"Munns CF, Rauch F, Zeitlin L, Fassier F, Glorieux FH . Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. J Bone Miner Res 2004;19:1779\u201386.","journal-title":"J Bone Miner Res"},{"key":"BFpr2012118_CR4","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.bone.2006.10.010","volume":"40","author":"C Land","year":"2007","unstructured":"Land C, Rauch F, Travers R, Glorieux FH . Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment. Bone 2007;40:638\u201344.","journal-title":"Bone"},{"key":"BFpr2012118_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1056\/NEJMoa023110","volume":"349","author":"MP Whyte","year":"2003","unstructured":"Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S . Bisphosphonate-induced osteopetrosis. N Engl J Med 2003;349:457\u201363.","journal-title":"N Engl J Med"},{"key":"BFpr2012118_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1210\/er.2007-0014","volume":"29","author":"AE Kearns","year":"2008","unstructured":"Kearns AE, Khosla S, Kostenuik PJ . Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev 2008;29:155\u201392.","journal-title":"Endocr Rev"},{"key":"BFpr2012118_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1359\/jbmr.0809010","volume":"24","author":"JP Brown","year":"2009","unstructured":"Brown JP, Prince RL, Deal C, et al. Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial. J Bone Miner Res 2009;24:153\u201361.","journal-title":"J Bone Miner Res"},{"key":"BFpr2012118_CR8","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1200\/JCO.2008.16.3832","volume":"26","author":"GK Ellis","year":"2008","unstructured":"Ellis GK, Bone HG, Chlebowski R, et al. Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer. J Clin Oncol 2008;26:4875\u201382.","journal-title":"J Clin Oncol"},{"key":"BFpr2012118_CR9","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","volume":"13","author":"WC Dougall","year":"1999","unstructured":"Dougall WC, Glaccum M, Charrier K, et al. RANK is essential for osteoclast and lymph node development. Genes Dev 1999;13:2412\u201324.","journal-title":"Genes Dev"},{"key":"BFpr2012118_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1359\/jbmr.081112","volume":"24","author":"PJ Kostenuik","year":"2009","unstructured":"Kostenuik PJ, Nguyen HQ, McCabe J, et al. Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine\/human) RANKL. J Bone Miner Res 2009;24:182\u201395.","journal-title":"J Bone Miner Res"},{"key":"BFpr2012118_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10585-007-9127-1","volume":"25","author":"JR Canon","year":"2008","unstructured":"Canon JR, Roudier M, Bryant R, et al. Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis. Clin Exp Metastasis 2008;25:119\u201329.","journal-title":"Clin Exp Metastasis"},{"key":"BFpr2012118_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/jor.20469","volume":"26","author":"D Delos","year":"2008","unstructured":"Delos D, Yang X, Ricciardi BF, Myers ER, Bostrom MP, Camacho NP . The effects of RANKL inhibition on fracture healing and bone strength in a mouse model of osteogenesis imperfecta. J Orthop Res 2008;26:153\u201364.","journal-title":"J Orthop Res"},{"key":"BFpr2012118_CR13","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1359\/jbmr.060905","volume":"21","author":"HK Kim","year":"2006","unstructured":"Kim HK, Morgan-Bagley S, Kostenuik P . RANKL inhibition: a novel strategy to decrease femoral head deformity after ischemic osteonecrosis. J Bone Miner Res 2006;21:1946\u201354.","journal-title":"J Bone Miner Res"},{"key":"BFpr2012118_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4049\/jimmunol.179.1.266","volume":"179","author":"RE Miller","year":"2007","unstructured":"Miller RE, Branstetter D, Armstrong A, et al. Receptor activator of NF-kappa B ligand inhibition suppresses bone resorption and hypercalcemia but does not affect host immune responses to influenza infection. J Immunol 2007;179:266\u201374.","journal-title":"J Immunol"},{"key":"BFpr2012118_CR15","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00198-007-0363-7","volume":"18","author":"MS Ominsky","year":"2007","unstructured":"Ominsky MS, Kostenuik PJ, Cranmer P, Smith SY, Atkinson JE . The RANKL inhibitor OPG-Fc increases cortical and trabecular bone mass in young gonad-intact cynomolgus monkeys. Osteoporos Int 2007;18:1073\u201382.","journal-title":"Osteoporos Int"},{"key":"BFpr2012118_CR16","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1359\/jbmr.080109","volume":"23","author":"MS Ominsky","year":"2008","unstructured":"Ominsky MS, Li X, Asuncion FJ, et al. RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats. J Bone Miner Res 2008;23:672\u201382.","journal-title":"J Bone Miner Res"},{"key":"BFpr2012118_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00223-005-0161-1","volume":"78","author":"J Padagas","year":"2006","unstructured":"Padagas J, Colloton M, Shalhoub V, et al. The receptor activator of nuclear factor-kappaB ligand inhibitor osteoprotegerin is a bone-protective agent in a rat model of chronic renal insufficiency and hyperparathyroidism. Calcif Tissue Int 2006;78:35\u201344.","journal-title":"Calcif Tissue Int"},{"key":"BFpr2012118_CR18","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1359\/JBMR.050601","volume":"20","author":"M Stolina","year":"2005","unstructured":"Stolina M, Adamu S, Ominsky M, et al. RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis. J Bone Miner Res 2005;20:1756\u201365.","journal-title":"J Bone Miner Res"},{"key":"BFpr2012118_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/art.11487","volume":"50","author":"J Zwerina","year":"2004","unstructured":"Zwerina J, Hayer S, Tohidast-Akrad M, et al. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. Arthritis Rheum 2004;50:277\u201390.","journal-title":"Arthritis Rheum"},{"key":"BFpr2012118_CR20","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1073\/pnas.96.7.3540","volume":"96","author":"H Hsu","year":"1999","unstructured":"Hsu H, Lacey DL, Dunstan CR, et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 1999; 96:3540\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFpr2012118_CR21","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1365-2141.2008.06983.x","volume":"140","author":"MK Askmyr","year":"2008","unstructured":"Askmyr MK, Fasth A, Richter J . Towards a better understanding and new therapeutics of osteopetrosis. Br J Haematol 2008;140:597\u2013609.","journal-title":"Br J Haematol"},{"key":"BFpr2012118_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/oxfordjournals.jhered.a108657","volume":"67","author":"SC Marks Jr","year":"1976","unstructured":"Marks SC Jr, Lane PW . Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse. J Hered 1976;67:11\u20138.","journal-title":"J Hered"},{"key":"BFpr2012118_CR23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1359\/jbmr.2003.18.1.108","volume":"18","author":"M Yoshino","year":"2003","unstructured":"Yoshino M, Yamazaki H, Yoshida H, et al. Reduction of osteoclasts in a critical embryonic period is essential for inhibition of mouse tooth eruption. J Bone Miner Res 2003;18:108\u201316.","journal-title":"J Bone Miner Res"},{"key":"BFpr2012118_CR24","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00198-011-1742-7","volume":"23","author":"R Bargman","year":"2012","unstructured":"Bargman R, Posham R, Boskey AL, DiCarlo E, Raggio C, Pleshko N . Comparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta. Osteoporos Int 2012;23:1141\u201350.","journal-title":"Osteoporos Int"},{"key":"BFpr2012118_CR25","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1073\/pnas.90.5.1701","volume":"90","author":"SD Chipman","year":"1993","unstructured":"Chipman SD, Sweet HO, McBride DJ Jr, et al. Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc Natl Acad Sci USA 1993;90:1701\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFpr2012118_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s002230010045","volume":"69","author":"NP Camacho","year":"2001","unstructured":"Camacho NP, Raggio CL, Doty SB, et al. A controlled study of the effects of alendronate in a growing mouse model of osteogenesis imperfecta. Calcif Tissue Int 2001;69:94\u2013101.","journal-title":"Calcif Tissue Int"},{"key":"BFpr2012118_CR27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1084\/jem.192.4.463","volume":"192","author":"H Min","year":"2000","unstructured":"Min H, Morony S, Sarosi I, et al. Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J Exp Med 2000; 192:463\u201374.","journal-title":"J Exp Med"},{"key":"BFpr2012118_CR28","first-page":"623","volume":"57","author":"I Kaczmarczyk-Sedlak","year":"2005","unstructured":"Kaczmarczyk-Sedlak I, Janiec W . Effects of catecholamines on blood pressure in the long bone marrow cavity in rats with bisphosphonate-induced osteopetrosis. Pharmacol Rep 2005;57:623\u201334.","journal-title":"Pharmacol Rep"},{"key":"BFpr2012118_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/BF02013722","volume":"12","author":"JJ Reynolds","year":"1973","unstructured":"Reynolds JJ, Murphy H, M\u00fchlbauer RC, Morgan DB, Fleisch H . Inhibition by diphosphonates of bone resorption in mice and comparison with grey-lethal osteopetrosis. Calcif Tissue Res 1973;12:59\u201371.","journal-title":"Calcif Tissue Res"},{"key":"BFpr2012118_CR30","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1902\/jop.2007.070073","volume":"78","author":"Q Jin","year":"2007","unstructured":"Jin Q, Cirelli JA, Park CH, et al. RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. J Periodontol 2007;78:1300\u20138.","journal-title":"J Periodontol"},{"key":"BFpr2012118_CR31","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/nm1197-1285","volume":"3","author":"V Iotsova","year":"1997","unstructured":"Iotsova V, Caama\u00f1o J, Loy J, Yang Y, Lewin A, Bravo R . Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med 1997;3:1285\u20139.","journal-title":"Nat Med"},{"key":"BFpr2012118_CR32","first-page":"509","volume":"52","author":"I Kaczmarczyk-Sedlak","year":"1995","unstructured":"Kaczmarczyk-Sedlak I . The effects of pamidronate on mechanical properties, growth and structural changes in rat bones. Acta Pol Pharm 1995; 52:509\u201313.","journal-title":"Acta Pol Pharm"},{"key":"BFpr2012118_CR33","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1359\/jbmr.080511","volume":"23","author":"MP Whyte","year":"2008","unstructured":"Whyte MP, McAlister WH, Novack DV, Clements KL, Schoenecker PL, Wenkert D . Bisphosphonate-induced osteopetrosis: novel bone modeling defects, metaphyseal osteopenia, and osteosclerosis fractures after drug exposure ceases. J Bone Miner Res 2008;23:1698\u2013707.","journal-title":"J Bone Miner Res"},{"key":"BFpr2012118_CR34","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/(SICI)1097-0185(199703)247:3<329::AID-AR4>3.0.CO;2-P","volume":"247","author":"P Lekic","year":"1997","unstructured":"Lekic P, Rubbino I, Krasnoshtein F, Cheifetz S, McCulloch CA, Tenenbaum H . Bisphosphonate modulates proliferation and differentiation of rat periodontal ligament cells during wound healing. Anat Rec 1997;247:329\u201340.","journal-title":"Anat Rec"},{"key":"BFpr2012118_CR35","first-page":"113","volume":"19","author":"T Kawata","year":"1999","unstructured":"Kawata T, Tokimasa C, Nowroozi N, et al. Lack of the bone remodeling in osteopetrotic (op\/op) mice associated with microdontia. J Craniofac Genet Dev Biol 1999;19:113\u20137.","journal-title":"J Craniofac Genet Dev Biol"},{"key":"BFpr2012118_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1538\/expanim.46.95","volume":"46","author":"S Niida","year":"1997","unstructured":"Niida S, Abe M, Suemune S, Yoshiko Y, Maeda N, Yamasaki A . Restoration of disturbed tooth eruption in osteopetrotic (op\/op) mice by injection of macrophage colony-stimulating factor. Exp Anim 1997;46:95\u2013101.","journal-title":"Exp Anim"},{"key":"BFpr2012118_CR37","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.archoralbio.2005.02.007","volume":"50","author":"J Heinrich","year":"2005","unstructured":"Heinrich J, Bsoul S, Barnes J, Woodruff K, Abboud S . CSF-1, RANKL and OPG regulate osteoclastogenesis during murine tooth eruption. Arch Oral Biol 2005;50:897\u2013908.","journal-title":"Arch Oral Biol"},{"key":"BFpr2012118_CR38","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1600-0722.2008.00529.x","volume":"116","author":"A Kamoun-Goldrat","year":"2008","unstructured":"Kamoun-Goldrat A, Ginisty D, Le Merrer M . Effects of bisphosphonates on tooth eruption in children with osteogenesis imperfecta. Eur J Oral Sci 2008;116:195\u20138.","journal-title":"Eur J Oral Sci"},{"key":"BFpr2012118_CR39","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1006\/jmbi.1994.1199","volume":"236","author":"M Raghunath","year":"1994","unstructured":"Raghunath M, Bruckner P, Steinmann B . Delayed triple helix formation of mutant collagen from patients with osteogenesis imperfecta. J Mol Biol 1994;236:940\u20139.","journal-title":"J Mol Biol"},{"key":"BFpr2012118_CR40","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S8756-3282(98)00141-0","volume":"23","author":"T Akatsu","year":"1998","unstructured":"Akatsu T, Murakami T, Ono K, et al. Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy. Bone 1998;23:495\u20138.","journal-title":"Bone"},{"key":"BFpr2012118_CR41","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1177\/002215540405200312","volume":"52","author":"L Filgueira","year":"2004","unstructured":"Filgueira L . Fluorescence-based staining for tartrate-resistant acidic phosphatase (TRAP) in osteoclasts combined with other fluorescent dyes and protocols. J Histochem Cytochem 2004;52:411\u20134.","journal-title":"J Histochem Cytochem"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr2012118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2012118","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2012118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:55:49Z","timestamp":1684472149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr2012118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,27]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["BFpr2012118"],"URL":"https:\/\/doi.org\/10.1038\/pr.2012.118","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,27]]},"assertion":[{"value":"26 August 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}